mRNA交付:通过聚合软纳米粒子的挑战和进步
Samaneh Yousefi Adlsadabad1, John W Hanrahan2, Ashok Kakkar1
1Department of Chemistry, McGill University, 801 Sherbrooke St West, Montreal, QC H3A 0B8, Canada.
International journal of molecular sciences
|February 10, 2024
概括
聚合物纳米粒子为信使核糖核酸 (mRNA) 疗法提供了先进的交付,克服了脂质纳米载体的局限性. 本综述探讨了用于mRNA传递的聚合结构的近期进展,旨在临床翻译.
科学领域:
- 生物技术是生物技术.
- 材料科学 材料科学 材料科学
- 纳米医学是一种纳米医学.
背景情况:
- 使者核糖核酸 (mRNA) 对于遗传信息传输和治疗应用至关重要.
- 脂质纳米载体在mRNA传递方面取得了成功,特别是在SARS-CoV-2疫苗中.
- 脂质纳米载体的局限性需要替代的mRNA疗法传递系统.
研究的目的:
- 审查用于信使核糖核酸 (mRNA) 传递的聚合物架构的最新进展.
- 讨论基于聚合物的mRNA输送系统的局限性和现有挑战.
- 为了促进聚合mRNA配方的进一步研究和临床翻译.
主要方法:
- 关于用于mRNA输送的聚合纳米粒子的最新科学文献的综述.
- 对定制基于宏分子的纳米载体的合成策略的分析.
- 评估诸如mRNA保护,加载效率和目标释放等参数.
主要成果:
- 基于聚合物的软纳米颗粒为mRNA输送提供了一个模块化平台.
- 合成关节允许量身定制的纳米载体特性,以增强mRNA传递.
- 最近的发展表明,克服现有的mRNA传递系统的局限性是有前途的.
结论:
- 聚合物架构正在成为用于mRNA传递的脂质纳米载体的有希望的替代品.
- 需要进一步的研究和开发,以应对临床翻译的现有挑战.
- 优化的聚合物纳米载体具有使用mRNA的各种治疗干预的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.


